Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Prades-Sagarra E"'
Publikováno v:
In Clinical and Translational Radiation Oncology November 2024 49
Autor:
Prades-Sagarra, E., Laarakker, F., Dissy, J., Lieuwes, N.G., Biemans, R., Dubail, M., Fouillade, C., Yaromina, A., Dubois, L.J.
Publikováno v:
In Radiotherapy and Oncology January 2024 190
Autor:
Khurshed M; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands., Prades-Sagarra E; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands., Saleh S; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands., Sminia P; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands., Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands., Molenaar RJ; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands., Crezee H; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands., van Noorden CJF; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, 1000 Ljubljana, Slovenia.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Dec 17; Vol. 14 (24). Date of Electronic Publication: 2022 Dec 17.
Publikováno v:
In Radiotherapy and Oncology May 2022 170 Supplement 1:S438-S439
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Koziol-White, Cynthia1 (AUTHOR) cjk167@rbhs.rutgers.edu, Gebski, Eric1 (AUTHOR), Cao, Gaoyaun1 (AUTHOR), Panettieri Jr., Reynold A.1 (AUTHOR)
Publikováno v:
Respiratory Research. 6/1/2024, Vol. 25, p1-21. 21p.
Autor:
KOTMAKÇI, Mustafa1 mustafa.kotmakci@ege.edu.tr, KANTARCI, Ayşe Gülten1, ÇETİNTAŞ, Vildan BOZOK2
Publikováno v:
Journal of Research in Pharmacy. 2023, Vol. 27 Issue 6, p2389-2398. 10p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Antioxidants; Apr2023, Vol. 12 Issue 4, p924, 23p
Autor:
Mohammed Khurshed, Elia Prades-Sagarra, Sarah Saleh, Peter Sminia, Johanna W. Wilmink, Remco J. Molenaar, Hans Crezee, Cornelis J. F. van Noorden
Publikováno v:
Cancers, 14(24):6228. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers; Volume 14; Issue 24; Pages: 6228
Khurshed, M, Prades-Sagarra, E, Saleh, S, Sminia, P, Wilmink, J W, Molenaar, R J, Crezee, H & van Noorden, C J F 2022, ' Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells ', Cancers, vol. 14, no. 24, 6228 . https://doi.org/10.3390/cancers14246228
Cancers; Volume 14; Issue 24; Pages: 6228
Khurshed, M, Prades-Sagarra, E, Saleh, S, Sminia, P, Wilmink, J W, Molenaar, R J, Crezee, H & van Noorden, C J F 2022, ' Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells ', Cancers, vol. 14, no. 24, 6228 . https://doi.org/10.3390/cancers14246228
Mutations in the isocitrate dehydrogenase 1 (IDH1MUT) gene occur in various types of malignancies, including ~60% of chondrosarcomas, ~30% of intrahepatic cholangiocarcinomas and >80% of low-grade gliomas. IDH1MUT are causal in the development and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e35fadd1195caa50a33d5fe32f89382
https://pure.amc.nl/en/publications/hyperthermia-as-a-potential-cornerstone-of-effective-multimodality-treatment-with-radiotherapy-cisplatin-and-parp-inhibitor-in-idh1mutated-cancer-cells(1b6df298-0130-4c36-9784-c15255383cfb).html
https://pure.amc.nl/en/publications/hyperthermia-as-a-potential-cornerstone-of-effective-multimodality-treatment-with-radiotherapy-cisplatin-and-parp-inhibitor-in-idh1mutated-cancer-cells(1b6df298-0130-4c36-9784-c15255383cfb).html